Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biopsy of Human Morula-Stage Embryos: Outcome of 215 IVF/ICSI Cycles with PGS

5 Sept 2014

Abstract excerpt

Preimplantation genetic diagnosis (PGD) is commonly performed on biopsies from 6-8-cell-stage embryos or blastocyst trophectoderm obtained on day 3 or 5, respectively. Day 4 human embryos at the morula stage were successfully biopsied. Biopsy was performed on 709 morulae from 215 ICSI cycles with preimplantation genetic screening (PGS), and 3-7 cells were obtained from each embryo. The most common vital...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Genetic Syndromes and Imprinting
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25191937
DOI: 10.1371/journal.pone.0106433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biopsy of Human Morula-Stage Embryos: Outcome of 215 IVF/ICSI Cycles with PGSPMID 25191937Read ↗

Aneuploidy rates and blastocyst formation after biopsy of morulae and early blastocysts on day 5Semantic proximity Read ↗

Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosisSemantic proximity Read ↗

New Perspectives on Embryo Biopsy: Not How, But When and Why?Semantic proximity Read ↗

Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVFSemantic proximity Read ↗

Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocationsSemantic proximity Read ↗

Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trialSemantic proximity Read ↗

Pregnancies following blastocyst stage transfer in PGD cycles at risk for beta-thalassaemic haemoglobinopathies.Semantic proximity Read ↗

Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitroSemantic proximity Read ↗

Preimplantation genetic diagnosis of chromosome abnormalities: implications from the outcome for couples with chromosomal rearrangementsSemantic proximity Read ↗

Ploidy and Implantation Potential: Non-Invasive Small Non-Coding RNA-Based Health Assessment of Days 5 and 6 BlastocystsSemantic proximity Read ↗

Preimplantation Genetic Screening (PGS) with Comparative Genomic Hybridization (CGH) following day 3 single cell blastomere biopsy markedly improves IVF outcomes while lowering multiple pregnancies and miscarriagesSemantic proximity Read ↗

Evaluation of day 5 versus day 6 blastocyst biopsy in preimplantation genetic testing: clinical and neonatal outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.